OncoImmunology
Volume 4, 2015 - Issue 5
Open access
2,153
Views
19
CrossRef citations to date
0
Altmetric
Author's View
Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
Nathalie VigneronLudwig Institute for Cancer Research; Brussels, Belgium;WELBIO (Walloon Excellence in Life Sciences and Biotechnology); Brussels, Belgium;de Duve Institute, Université catholique de Louvain, Brussels, Belgium
, Nicolas van BarenLudwig Institute for Cancer Research; Brussels, Belgium;de Duve Institute, Université catholique de Louvain, Brussels, Belgium
& Benoît J Van den EyndeLudwig Institute for Cancer Research; Brussels, Belgium;WELBIO (Walloon Excellence in Life Sciences and Biotechnology); Brussels, Belgium;de Duve Institute, Université catholique de Louvain, Brussels, BelgiumCorrespondence[email protected]
Article: e1003012
|
Received 16 Dec 2014, Accepted 23 Dec 2014, Published online: 21 May 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.